Accountable Action End Points for Evaluating Artificial Intelligence in Digital Public Health

• by Xiang Zhou, Hongyan Liu, Zhengdong Hua

• September 23, 2026

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• July 30, 2026

• 5 min

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

• by Kathryn Wighton

• August 28, 2026

• 2 min

Oropharyngeal swabs show higher bacterial loads than nasopharyngeal swabs for PCR detection of pertussis: a multicenter prospective study

• by Kentaro Wakamatsu, Yoshifumi Tananari, Kimiko Nakamura, Teru Nakamura, Ryoichi Yamakawa, Toshinobu Matsuura, Kyoko Yamakawa, Kuniko Tananari, Mitsuru Iseda, Chikage Tokunaga, Chiyoko Bando, Zenzo Nagasawa, Kouta Katsuki, Sae Kawamoto, Ruriko Kiyotani, Izumi Fukui, Satomi Asai, Nobuhiko Nagata, Hozumi Yamada

• July 17, 2026